National Institute of General Medical Sciences; Notice of Closed Meetings, 13689 [2013-04579]
Download as PDF
<![CDATA[
13689
Federal Register / Vol. 78, No. 40 / Thursday, February 28, 2013 / Notices
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection: Request for
Human Embryonic Stem Cell Line to be
Approved for Use in NIH Funded
Research. OMB No. 0925–0601—
Expiration Date 4/30/2013—Extension—
Office of Extramural Research (OER),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The form is used by
applicants to request that human
embryonic stem cell lines be approved
for use in NIH funded research.
Applicants may submit applications at
any time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
3,375.
To Submit Comments and For Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Dr. Ellen Gadbois,
Office of Science Policy, Office of the
Director, NIH, Building 1, Room 218,
MSC 0166, 9000 Rockville Pike,
Bethesda, MD 20892, or call non-tollfree number (301)–496–1454 or Email
your request, including your address to:
gadboisel@od.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
Number of
respondents
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hour
NIH grantees and others with hESC lines .......................................................
50
3
22.5
3,375
Dated: February 21, 2013.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2013–04669 Filed 2–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Program Projects in Drug Metabolism.
Date: March 22, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
19:12 Feb 27, 2013
Jkt 229001
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.18K, Bethesda, MD
20892, 301–594–3907, pikbr@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Clinical Trials: Sepsis.
Date: March 25, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892, 301–594–
3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Dated: February 21, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–04579 Filed 2–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel.
Date: March 8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 78, Number 40 (Thursday, February 28, 2013)]
[Notices]
[Page 13689]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04579]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Program Projects in Drug
Metabolism.
Date: March 22, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Room 3An.18K, Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Brian R. Pike, Ph.D., Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892, 301-594-3907, pikbr@mail.nih.gov.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Clinical Trials: Sepsis.
Date: March 25, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Room 3An.18K, Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Brian R. Pike, Ph.D., Scientific Review Officer,
National Institute of General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3An.18K, Bethesda, MD 20892, 301-
594-3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National Institutes of Health, HHS)
Dated: February 21, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-04579 Filed 2-27-13; 8:45 am]
BILLING CODE 4140-01-P
